These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38567803)

  • 41. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
    Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J
    Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
    Xylinas E; Kluth L; Passoni N; Trinh QD; Rieken M; Lee RK; Fajkovic H; Novara G; Margulis V; Raman JD; Lotan Y; Rouprêt M; Aziz A; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Walton T; Karakiewicz PI; Montorsi F; Zerbib M; Scherr DS; Shariat SF;
    Eur Urol; 2014 Mar; 65(3):650-8. PubMed ID: 24070577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.
    Chung Y; Lee DH; Lee M; Kim H; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
    Investig Clin Urol; 2020 Mar; 61(2):158-165. PubMed ID: 32158966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
    Thalmann GN; Markwalder R; Walter B; Studer UE
    J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Naser-Tavakolian A; Ghodoussipour S; Djaladat H
    Curr Opin Urol; 2019 May; 29(3):189-197. PubMed ID: 30762673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bladder tumor recurrence after primary surgery for transitional cell carcinoma of the upper urinary tract.
    Oehlschläger S; Baldauf A; Wiessner D; Gellrich J; Hakenberg OW; Wirth MP
    Urol Int; 2004; 73(3):209-11. PubMed ID: 15539838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study.
    Xylinas E; Colin P; Audenet F; Phe V; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Polguer T; Ruffion A; Valeri A; Rozet F; Long JA; Zerbib M; Rouprêt M
    World J Urol; 2013 Feb; 31(1):61-8. PubMed ID: 23053211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Remaining Ipsilateral Ureteral Orifice Provokes Intravesical Tumor Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Study With a Mid-Term Follow-Up.
    Kwon SY; Ko YH; Song PH; Kim BH; Kim BS; Kim TH;
    Urology; 2020 Nov; 145():166-171. PubMed ID: 32791287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract.
    Strong DW; Pearse HD
    Cancer; 1976 Nov; 38(5):2173-83. PubMed ID: 991130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and validation of a prognostic nomogram for patients with intravesical recurrence after radical nephroureterectomy for non-metastatic upper tract urothelial carcinoma.
    Hou G; Zheng Y; Zhang L; Lai D; Wang F; Li X; Yan F; Tian J; Zhang G; Meng P; Wei D; Zhu Z; Yuan J; Hui Q; Yuan J
    World J Urol; 2020 Aug; 38(8):1969-1975. PubMed ID: 31654221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes.
    Belhadj Y; Grande P; Seisen T; Gobert A; Gomez FD; Cussenot O; Roupret M
    BJU Int; 2019 Apr; 123(4):618-623. PubMed ID: 30548115
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
    Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
    J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial comment on: significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Sagalowsky AI
    Eur Urol; 2008 Nov; 54(5):1134-5. PubMed ID: 18243496
    [No Abstract]   [Full Text] [Related]  

  • 54. Oncologic outcomes and survival in pT0 tumors after radical nephroureterectomy for upper tract urothelial carcinoma: results from of a large multicenter international collaborative study.
    Rouprêt M; Xylinas E; Colin P; Kluth L; Karakiewicz P; Shariat SF
    Eur Urol; 2013 Feb; 63(2):404-5. PubMed ID: 23040206
    [No Abstract]   [Full Text] [Related]  

  • 55. [Nephroureterectomy for upper tract urothelial carcinoma : Effectiveness of single-dose intravesical chemotherapy].
    Spek A
    Urologe A; 2020 Apr; 59(4):480-483. PubMed ID: 32100070
    [No Abstract]   [Full Text] [Related]  

  • 56. The method of bladder cuff excision during laparoscopic radical nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma.
    Allard CB; Alamri A; Dason S; Farrokhyar F; Matsumoto ED; Kapoor A
    World J Urol; 2013 Feb; 31(1):175-81. PubMed ID: 22843075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of post-operative intravesical recurrence and oncological outcomes after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Zou L; Zhang L; Zhang H; Jiang H; Ding Q
    World J Urol; 2014 Apr; 32(2):565-70. PubMed ID: 24022234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Previous or Synchronous Non-Muscle Invasive Bladder Cancer on Clinical Results after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multi-Institutional Study.
    Kim BW; Ha YS; Lee JN; Kim HT; Kim TH; Lee JK; Byun SS; Choi YD; Kang HW; Yun SJ; Kim WJ; Kwon YS; Kwon TG
    Urol J; 2015 Sep; 12(4):2233-9. PubMed ID: 26341764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oncological impact of endoscopic bladder cuff management during nephroureterectomy varies according to upper urinary tract tumor location.
    Luo HL; Kang CH; Chen YT; Chuang YC; Cheng YT; Lee WC; Chiang PH
    Int J Urol; 2014 Apr; 21(4):366-9. PubMed ID: 24118071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.